Wiz Khalifa Partners with Supreme to Expand Cannabis Brand
Ryan Allway
December 18th, 2018
Exclusive, News, Top News
The music industry has become increasingly intertwined with the cannabis industry over the past several years. With the partnership between Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Snoop Dogg in 2016, these relationships grew even closer on an international level. Cannabis companies around the world have sought out ways to partner with these musicians to leverage their cannabis expertise.
The Supreme Cannabis Company Inc. (TSX-V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently announced an exclusive consulting agreement with Wiz Khalifa’s Khalifa Kush Enterprises (KKE) to develop and launch a line of premium cannabis products into the nascent Canadian market. The move could bring KKE’s tremendously successful strains in the United States market north of the border into Canada’s newly recreational market.
The Cannabis Tastemaker
Wiz Khalifa is a Grammy Award-winning American rapper, singer, songwriter, and actor that has become an icon within the cannabis community. After partnering with Colorado-based RiverRock Cannabis in 2016, Khalifa developed his own line of regulated marijuana strains, products, and concentrates under the Khalifa Kush brand. These products have already hit dispensary shelves across most states where cannabis has been legalized.
In addition to creating his own cannabis strains, the musician has taken other avenues to raise awareness for the cannabis industry. He launched Weed Farm on 4/20 last year—a mobile game where players can operate their own marijuana businesses—and continues to release albums, like Rolling Papers, that are cannabis-focused. He also continues to perform at cannabis cups and other industry events around the world.
The move follows many other high-profile celebrities that have introduced their own brands, including Snoop Dogg’s Leafs by Snoop, Bob Marley’s (heirs) Marley Naturals, Margaret Cho’s Cho-G, Willie Nelson’s Willie’s Reserve, and Tommy Chong’s Chong’s Choice. The popularity of these cannabis icons has made them extremely valuable to cannabis companies in the United States looking to expand consumer awareness.
Expansion into Canada
The Supreme Cannabis Company recently announced an exclusive consulting services agreement with Khalifa Kush Enterprises Canada ULC—an affiliate of Khalifa Kush Enterprises LLC in the United States. Under the terms of the agreement, the two companies will develop and launch a line of premium cannabis products under the KKE brand and distribute them through Canada’s nascent recreational market.
“Canada is a very important place to me with the idea for ‘Kush and Orange Juice’ being created in Toronto, it’s the perfect start for the international expansion of Khalifa Kush,” said Wiz Khalifa, Principal of KKE. “My team and I have spent the past year finding a partner that shares our vision, values, and passion for cannabis. The team at Supreme Cannabis understands the importance of high quality cannabis and how to produce [it at scale].”
Supreme Cannabis will have exclusive rights to the KKE brand within Canada, as well as potential expansion into international markets, pending approval from KKE and the legal status of the products in those markets. While celebrity endorsements aren’t permitted by Health Canada, the KKE brand’s strong reputation in the United States could help reassure customers of the ultra-premium quality of the cannabis.
“Wiz is a globally-recognized cannabis taste maker and connoisseur,” said Supreme Cannabis President John Fowler. “I was impressed by the quality of the ‘Khalifa Kush’ strain and the level of care and involvement Wiz had with developing the strain and working with cultivators to continue to improve quality batch-by-batch. We’re excited to be working with KKE Canada to build out another brand with the same commitment to quality.”
Looking Ahead
The Supreme Cannabis Company Inc. (TSX-V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) represents a compelling investment opportunity in Canada’s cannabis industry. In addition to its partnership with Wiz Khalifa, the company’s 7ACRES licensed producer subsidiary operates a 342,000 sq. ft. facility in Ontario that has already secured numerous provincial supply agreements and consistently ranks high among recreational brands.
The company’s portfolio also includes an equity investment and long-term global distribution partnership with Lesotho-based Medigrow for the exportation of medical-grade cannabis oil.
For more information, visit the company’s website at www.supreme.ca.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
MediPharm is a pioneer in the cannabis industry as it is the first company in Canada to successfully become a Licensed Producer for cannabis oil production without first receiving a cannabis cultivation license.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
